Page last updated: 2024-10-29

ketoconazole and Buruli Ulcer Disease

ketoconazole has been researched along with Buruli Ulcer Disease in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Habib, A1
D Almeida, C1
Degboe, B1
Morvant, B1
Ganlonon, ML1
Adeye, A1
Croue, A1
Kiki, M1
Sodjinou, E1

Other Studies

1 other study available for ketoconazole and Buruli Ulcer Disease

ArticleYear
Disseminated and ulcerative basidiobolomycosis simulating a Buruli ulcer in an immunocompetent girl in Southern Benin.
    The Pan African medical journal, 2020, Volume: 37

    Topics: Antifungal Agents; Benin; Buruli Ulcer; Child, Preschool; Combined Modality Therapy; Dermatomycoses;

2020